These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 25073788)
1. A multicentre pilot study investigating high-definition optical coherence tomography in the differentiation of cutaneous melanoma and melanocytic naevi. Gambichler T; Schmid-Wendtner MH; Plura I; Kampilafkos P; Stücker M; Berking C; Maier T J Eur Acad Dermatol Venereol; 2015 Mar; 29(3):537-41. PubMed ID: 25073788 [TBL] [Abstract][Full Text] [Related]
2. In vivo assessment of optical properties of melanocytic skin lesions and differentiation of melanoma from non-malignant lesions by high-definition optical coherence tomography. Boone MA; Suppa M; Dhaenens F; Miyamoto M; Marneffe A; Jemec GB; Del Marmol V; Nebosis R Arch Dermatol Res; 2016 Jan; 308(1):7-20. PubMed ID: 26563265 [TBL] [Abstract][Full Text] [Related]
3. High-definition optical coherence tomography of melanocytic skin lesions. Gambichler T; Plura I; Schmid-Wendtner M; Valavanis K; Kulichova D; Stücker M; Pljakic A; Berking C; Maier T J Biophotonics; 2015 Aug; 8(8):681-6. PubMed ID: 25237005 [TBL] [Abstract][Full Text] [Related]
4. High-definition optical coherence tomography imaging of melanocytic lesions: a pilot study. Boone MA; Norrenberg S; Jemec GB; Del Marmol V Arch Dermatol Res; 2014 Jan; 306(1):11-26. PubMed ID: 23832144 [TBL] [Abstract][Full Text] [Related]
5. Characterization of benign and malignant melanocytic skin lesions using optical coherence tomography in vivo. Gambichler T; Regeniter P; Bechara FG; Orlikov A; Vasa R; Moussa G; Stücker M; Altmeyer P; Hoffmann K J Am Acad Dermatol; 2007 Oct; 57(4):629-37. PubMed ID: 17610989 [TBL] [Abstract][Full Text] [Related]
7. High-definition optical coherence tomography algorithm for discrimination of basal cell carcinoma from clinical BCC imitators and differentiation between common subtypes. Boone MA; Suppa M; Pellacani G; Marneffe A; Miyamoto M; Alarcon I; Ruini C; Hofmann-Wellenhof R; Malvehy J; Jemec GB; Del Marmol V J Eur Acad Dermatol Venereol; 2015 Sep; 29(9):1771-80. PubMed ID: 25712021 [TBL] [Abstract][Full Text] [Related]
8. Validation of a diagnostic algorithm for the discrimination of actinic keratosis from normal skin and squamous cell carcinoma by means of high-definition optical coherence tomography. Marneffe A; Suppa M; Miyamoto M; Del Marmol V; Boone M Exp Dermatol; 2016 Sep; 25(9):684-7. PubMed ID: 27095632 [TBL] [Abstract][Full Text] [Related]
9. Ex vivo high-definition optical coherence tomography of basal cell carcinoma compared to frozen-section histology in micrographic surgery: a pilot study. Maier T; Kulichová D; Ruzicka T; Kunte C; Berking C J Eur Acad Dermatol Venereol; 2014 Jan; 28(1):80-5. PubMed ID: 23279136 [TBL] [Abstract][Full Text] [Related]
10. Histopathological correlates of basal cell carcinoma in the slice and en face imaging modes of high-definition optical coherence tomography. Gambichler T; Plura I; Kampilafkos P; Valavanis K; Sand M; Bechara FG; Stücker M Br J Dermatol; 2014 Jun; 170(6):1358-61. PubMed ID: 24359160 [TBL] [Abstract][Full Text] [Related]
11. Digital image analysis for diagnosis of cutaneous melanoma. Development of a highly effective computer algorithm based on analysis of 837 melanocytic lesions. Blum A; Luedtke H; Ellwanger U; Schwabe R; Rassner G; Garbe C Br J Dermatol; 2004 Nov; 151(5):1029-38. PubMed ID: 15541081 [TBL] [Abstract][Full Text] [Related]
12. Assessment of optical coherence tomography imaging in the diagnosis of non-melanoma skin cancer and benign lesions versus normal skin: observer-blinded evaluation by dermatologists and pathologists. Mogensen M; Joergensen TM; Nürnberg BM; Morsy HA; Thomsen JB; Thrane L; Jemec GB Dermatol Surg; 2009 Jun; 35(6):965-72. PubMed ID: 19397661 [TBL] [Abstract][Full Text] [Related]
13. Sensitivity, specificity, and diagnostic accuracy of three dermoscopic algorithmic methods in the diagnosis of doubtful melanocytic lesions: the importance of light brown structureless areas in differentiating atypical melanocytic nevi from thin melanomas. Annessi G; Bono R; Sampogna F; Faraggiana T; Abeni D J Am Acad Dermatol; 2007 May; 56(5):759-67. PubMed ID: 17316894 [TBL] [Abstract][Full Text] [Related]
14. Morphological evaluation of melanocytic lesions with three-dimensional line-field confocal optical coherence tomography: correlation with histopathology and reflectance confocal microscopy. A pilot study. Perez-Anker J; Puig S; Alos L; García A; Alejo B; Cinotti E; Orte Cano C; Tognetti L; Lenoir C; Monnier J; Machuca N; Castillo P; Gibert PR; Rubegni P; Suppa M; Perrot JL; Del Marmol V; Malvehy J Clin Exp Dermatol; 2022 Dec; 47(12):2222-2233. PubMed ID: 35988042 [TBL] [Abstract][Full Text] [Related]
15. The value of cyclooxygenase-2 expression in differentiating between early melanomas and histopathologically difficult types of benign human skin lesions. Kuźbicki Ł; Lange D; Strączyńska-Niemiec A; Chwirot BW Melanoma Res; 2012 Feb; 22(1):70-6. PubMed ID: 22228276 [TBL] [Abstract][Full Text] [Related]
16. Distribution and colocalization of markers for proliferation, invasion, motility and neoangiogenesis in benign melanocytic naevi and malignant melanomas. Fröhlich E; Mack AF; Garbe C; Klessen C Br J Dermatol; 2005 Dec; 153(6):1159-65. PubMed ID: 16307652 [TBL] [Abstract][Full Text] [Related]